ProSomnus is the leading non-CPAP OSA therapy™ for the treatment of Obstructive Sleep Apnea (OSA), a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance sponsored healthcare plans around the world. To learn more visit

Website: https://prosomnus.com/

Contact: contactnl@prosomnus.com

Global Headquarters

ProSomnus® Sleep Technologies

5675 Gibraltar Drive

Pleasanton, CA 94588, USA